These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

204 related items for PubMed ID: 24004587

  • 1. [Activation of mTOR in maldeveloped balloon cells and dysmorphic neurons of type II focal cortical dysplasia].
    Lin K, Lin YX, Kang DZ, Ye ZX, Wang XF.
    Zhonghua Bing Li Xue Za Zhi; 2013 May; 42(5):311-5. PubMed ID: 24004587
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. FCD Type II and mTOR pathway: Evidence for different mechanisms involved in the pathogenesis of dysmorphic neurons.
    Rossini L, Villani F, Granata T, Tassi L, Tringali G, Cardinale F, Aronica E, Spreafico R, Garbelli R.
    Epilepsy Res; 2017 Jan; 129():146-156. PubMed ID: 28056425
    [Abstract] [Full Text] [Related]

  • 4. mTOR-dependent abnormalities in autophagy characterize human malformations of cortical development: evidence from focal cortical dysplasia and tuberous sclerosis.
    Yasin SA, Ali AM, Tata M, Picker SR, Anderson GW, Latimer-Bowman E, Nicholson SL, Harkness W, Cross JH, Paine SM, Jacques TS.
    Acta Neuropathol; 2013 Aug; 126(2):207-18. PubMed ID: 23728790
    [Abstract] [Full Text] [Related]

  • 5. [Expression of PI3K pathway proteins in refractory epilepsy associated with cortical malformation development].
    Ni HC, Sun FH, Piao YS, Ma XL, Lu DH.
    Zhonghua Bing Li Xue Za Zhi; 2012 Jun; 41(6):391-5. PubMed ID: 22932407
    [Abstract] [Full Text] [Related]

  • 6. Insulin signaling pathways in cortical dysplasia and TSC-tubers: tissue microarray analysis.
    Miyata H, Chiang AC, Vinters HV.
    Ann Neurol; 2004 Oct; 56(4):510-9. PubMed ID: 15455398
    [Abstract] [Full Text] [Related]

  • 7. Activation of extracellular regulated kinase and mechanistic target of rapamycin pathway in focal cortical dysplasia.
    Patil VV, Guzman M, Carter AN, Rathore G, Yoshor D, Curry D, Wilfong A, Agadi S, Swann JW, Adesina AM, Bhattacharjee MB, Anderson AE.
    Neuropathology; 2016 Apr; 36(2):146-56. PubMed ID: 26381727
    [Abstract] [Full Text] [Related]

  • 8. mTOR pathway activation in focal cortical dysplasia.
    Kumari K, Sharma MC, Kakkar A, Malgulwar PB, Pathak P, Suri V, Sarkar C, Chandra SP, Faruq M.
    Ann Diagn Pathol; 2020 Jun; 46():151523. PubMed ID: 32325422
    [Abstract] [Full Text] [Related]

  • 9. Relationship between focal cortical dysplasia and epilepsy-associated low-grade tumors: an immunohistochemical study.
    Marucci G, Martinoni M, Giulioni M.
    APMIS; 2013 Jan; 121(1):22-9. PubMed ID: 23030838
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Long-duration epilepsy affects cell morphology and glutamatergic synapses in type IIB focal cortical dysplasia.
    Finardi A, Colciaghi F, Castana L, Locatelli D, Marras CE, Nobili P, Fratelli M, Bramerio MA, Lorusso G, Battaglia GS.
    Acta Neuropathol; 2013 Aug; 126(2):219-35. PubMed ID: 23793416
    [Abstract] [Full Text] [Related]

  • 13. Brain somatic mutations in MTOR cause focal cortical dysplasia type II leading to intractable epilepsy.
    Lim JS, Kim WI, Kang HC, Kim SH, Park AH, Park EK, Cho YW, Kim S, Kim HM, Kim JA, Kim J, Rhee H, Kang SG, Kim HD, Kim D, Kim DS, Lee JH.
    Nat Med; 2015 Apr; 21(4):395-400. PubMed ID: 25799227
    [Abstract] [Full Text] [Related]

  • 14. Pathophysiologic characteristics of balloon cells in cortical dysplasia.
    Oh HS, Lee MC, Kim HS, Lee JS, Lee JH, Kim MK, Woo YJ, Kim JH, Kim HI, Kim SU.
    Childs Nerv Syst; 2008 Feb; 24(2):175-83. PubMed ID: 17899129
    [Abstract] [Full Text] [Related]

  • 15. Dysregulation of NEUROG2 plays a key role in focal cortical dysplasia.
    Avansini SH, Torres FR, Vieira AS, Dogini DB, Rogerio F, Coan AC, Morita ME, Guerreiro MM, Yasuda CL, Secolin R, Carvalho BS, Borges MG, Almeida VS, Araújo PAOR, Queiroz L, Cendes F, Lopes-Cendes I.
    Ann Neurol; 2018 Mar; 83(3):623-635. PubMed ID: 29461643
    [Abstract] [Full Text] [Related]

  • 16. [Focal cortical dysplasia with refractory epilepsy: clinicopathologic study of 38 cases].
    Piao YS, Chen L, Fu YJ, Wang W, Li YJ, Lu DH.
    Zhonghua Bing Li Xue Za Zhi; 2007 Mar; 36(3):150-4. PubMed ID: 17535679
    [Abstract] [Full Text] [Related]

  • 17. Balloon cells promote immune system activation in focal cortical dysplasia type 2b.
    Zimmer TS, Broekaart DWM, Luinenburg M, Mijnsbergen C, Anink JJ, Sim NS, Michailidou I, Jansen FE, van Rijen PC, Lee JH, François L, van Eyll J, Dedeurwaerdere S, van Vliet EA, Mühlebner A, Mills JD, Aronica E.
    Neuropathol Appl Neurobiol; 2021 Oct; 47(6):826-839. PubMed ID: 34003514
    [Abstract] [Full Text] [Related]

  • 18. Focal malformations of cortical development: new vistas for molecular pathogenesis.
    Lim KC, Crino PB.
    Neuroscience; 2013 Nov 12; 252():262-76. PubMed ID: 23892008
    [Abstract] [Full Text] [Related]

  • 19. Altered inhibition in tuberous sclerosis and type IIb cortical dysplasia.
    Talos DM, Sun H, Kosaras B, Joseph A, Folkerth RD, Poduri A, Madsen JR, Black PM, Jensen FE.
    Ann Neurol; 2012 Apr 12; 71(4):539-51. PubMed ID: 22447678
    [Abstract] [Full Text] [Related]

  • 20. Dysregulation of the (immuno)proteasome pathway in malformations of cortical development.
    van Scheppingen J, Broekaart DW, Scholl T, Zuidberg MR, Anink JJ, Spliet WG, van Rijen PC, Czech T, Hainfellner JA, Feucht M, Mühlebner A, van Vliet EA, Aronica E.
    J Neuroinflammation; 2016 Aug 26; 13(1):202. PubMed ID: 27566410
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.